News

MyChesCo on MSN9d
ENHERTU Shows Promise in Early-Stage HER2-Positive Breast Cancer
Positive results from the DESTINY-Breast11 Phase III trial revealed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), when ...
MarketWatch11d
5 charts that show how Trump’s first 100 days have shaped Americans’ finances
After years of high inflation, President Donald Trump won back the White House on a promise to lower prices and improve Americans’ personal finances. “As president, I’m fighting every day to ...
Clinical Trials Arena on MSN16d
AstraZeneca and Daiichi’s Enhertu shows pCR rate improvement in breast cancer trial
The trial’s primary endpoint is pCR, with secondary endpoints including event-free survival (EFS), overall survival, safety, and invasive disease-free survival.
PMLiVE16d
AstraZeneca/Daiichi Sankyo share positive phase 3 results for Enhertu in early breast cancer
Enhertu (trastuzumab deruxtecan) in a subset of early-stage breast cancer patients. The phase 3 DESTINY-Breast11 trial has been evaluating the drug followed by paclitaxel, trastuzumab and pertuzumab ...
Seeking Alpha16d
AstraZeneca, Daiichi post late-stage trial win for Enhertu in early-stage breast cancer
AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSNKY) announced Wednesday that Enhertu, their jointly developed antibody-drug conjugate, reached the main goal in a Phase 3 trial in certain ...
Yahoo Finance17d
ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete ...
May 07, 2025--(BUSINESS WIRE)--Positive high-level results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab ... rate versus standard of care (dose-dense doxorubicin ...
Investing17d
Enhertu shows promise in early-stage breast cancer trial
LONDON - AstraZeneca PLC (LON:AZN) and Daiichi Sankyo Company, Limited have announced that their drug Enhertu (trastuzumab deruxtecan) has shown a statistically significant improvement in ...
Yahoo Finance17d
ENHERTU® Followed by THP Before Surgery Showed Statistically Significant and Clinically Meaningful Improvement in Pathologic Complete Response in Patients With High-Risk HER2 ...
TOKYO & BASKING RIDGE, N.J., May 07, 2025--(BUSINESS WIRE)--Positive topline results from the DESTINY-Breast11 phase 3 trial showed ENHERTU ... standard of care (dose-dense doxorubicin and ...
FierceBiotech24d
Roche receives FDA breakthrough label for AI-powered lung cancer companion diagnostic test
Roche's Enhertu companion diagnostic secures new FDA approval in HER2-ultralow breast cancer Roche’s companion diagnostic test aims to identify patients with advanced or metastatic NSCLC who may ...
Morningstar25d
Daiichi Sankyo's World-Leading Antibody Drug Conjugate Platform Continues to Make Progress
In 2019 it formed a partnership with AstraZeneca and will co-develop and co-commercialize Enhertu and Datroway ... which limits the dosing that is tolerable for patients before severe systemic ...
USA Today26d
Green Bay Packers WR depth chart after drafting Matthew Golden, Savion Williams
Green Bay, Wisconsin, hosted the NFL draft for the first time this year. The three-day event came to the home of one of the oldest franchises in the NFL and hundreds of thousands of fans flocked ...